메뉴 건너뛰기




Volumn 127, Issue 16, 2014, Pages 2894-2899

Tartrate-resistant acid phosphatase 5b is a potential biomarker for rheumatoid arthritis: A pilot study in han chinese

Author keywords

Biologic agent; Chinese; Osteoclast; Rheumatoid arthritis; Tartrate resistant acid phosphatase 5b

Indexed keywords

ACID PHOSPHATASE; BIOLOGICAL MARKER; INFLIXIMAB; ISOENZYME; METHOTREXATE; MONOCLONAL ANTIBODY; TARTRATE-RESISTANT ACID PHOSPHATASE;

EID: 84906482678     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20140670     Document Type: Article
Times cited : (13)

References (25)
  • 1
    • 0038011833 scopus 로고    scopus 로고
    • Evolving concepts of rheumatoid arthritis
    • Firestein GS. Evolving concepts of rheumatoid arthritis.Nature 2003;423: 356-361.
    • (2003) Nature , vol.423 , pp. 356-361
    • Firestein, G.S.1
  • 3
    • 34247589636 scopus 로고    scopus 로고
    • Cells of the synovium in rheumatoid arthritis
    • Schett G. Cells of the synovium in rheumatoid arthritis. Osteoclasts. Arthritis Res Ther 2007;9: 203.
    • (2007) Osteoclasts. Arthritis Res Ther , vol.9 , pp. 203
    • Schett, G.1
  • 4
    • 80053474869 scopus 로고    scopus 로고
    • Changes in serum levels of soluble osteoclast-associated receptor in human rheumatoid arthritis
    • Zhao S Guo, YY Ding N, Yang LL Zhang N, Changes in serum levels of soluble osteoclast-associated receptor in human rheumatoid arthritis. Chin Med J.2011; 124: 3058-3060.
    • (2011) Chin Med J , vol.124 , pp. 3058-3060
    • Zhao, S.G.1    Ding, Y.Y.N.2    Yang, L.L.3    Zhang, N.4
  • 5
    • 0028865923 scopus 로고
    • Immunohistochemical detection of tartrate-resistant acid phosphatase in non-hematopoietic human tissues
    • Yaziji H, Janckila AJ, Lear SC, Martin AW, Yam LT. Immunohistochemical detection of tartrate-resistant acid phosphatase in non-hematopoietic human tissues. Am J Clin Pathol 1995; 104: 397-402.
    • (1995) Am J Clin Pathol , vol.104 , pp. 397-402
    • Yaziji, H.1    Janckila, A.J.2    Lear, S.C.3    Martin, A.W.4    Yam, L.T.5
  • 6
    • 47849116207 scopus 로고    scopus 로고
    • Significance of serum TRACP in rheumatoid arthritis
    • Janckila AJ, Neustadt DH, Yam LT. Significance of serum TRACP in rheumatoid arthritis. J Bone Miner Res 2008; 23: 1287-1295.
    • (2008) J Bone Miner Res , vol.23 , pp. 1287-1295
    • Janckila, A.J.1    Neustadt, D.H.2    Yam, L.T.3
  • 7
    • 0023945481 scopus 로고
    • The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis
    • Arnet FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
    • (1988) Arthritis Rheum , vol.31 , pp. 315-324
    • Arnet, F.C.1    Edworthy, S.M.2    Bloch, D.A.3    McShane, D.J.4    Fries, J.F.5    Cooper, N.S.6
  • 8
    • 0026629688 scopus 로고
    • The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis
    • Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 1992; 35: 498-502.
    • (1992) Arthritis Rheum , vol.35 , pp. 498-502
    • Hochberg, M.C.1    Chang, R.W.2    Dwosh, I.3    Lindsey, S.4    Pincus, T.5    Wolfe, F.6
  • 9
    • 72649098710 scopus 로고
    • Therapeutic criteria in rheumatoid arthritis
    • Steinbrocker O, Traeger C, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 659-662.
    • (1949) JAMA , vol.140 , pp. 659-662
    • Steinbrocker, O.1    Traeger, C.2    Batterman, R.C.3
  • 11
    • 0035148965 scopus 로고    scopus 로고
    • Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity
    • Janckila AJ, Takahashi K, Sun SZ, Yam LT. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity. Clin Chem 2001; 47: 174-178.
    • (2001) Clin Chem , vol.47 , pp. 174-178
    • Janckila, A.J.1    Takahashi, K.2    Sun, S.Z.3    Yam, L.T.4
  • 12
    • 0031894140 scopus 로고    scopus 로고
    • Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis
    • Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 1998; 152: 943-951.
    • (1998) Am J Pathol , vol.152 , pp. 943-951
    • Gravallese, E.M.1    Harada, Y.2    Wang, J.T.3    Gorn, A.H.4    Thornhill, T.S.5    Goldring, S.R.6
  • 13
    • 0942300651 scopus 로고    scopus 로고
    • Clinical performance of immunoreactive tartrateresistant acid phosphatase isoform 5b as a marker of bone resorption
    • Hannon RA, Clowes JA, Eagleton AC, Al Hadari A, Eastell R, Blumsohn A. Clinical performance of immunoreactive tartrateresistant acid phosphatase isoform 5b as a marker of bone resorption. Bone 2004; 34: 187-189.
    • (2004) Bone , vol.34 , pp. 187-189
    • Hannon, R.A.1    Clowes, J.A.2    Eagleton, A.C.3    Al, H.A.4    Eastell, R.5    Blumsohn, A.6
  • 15
    • 0038166881 scopus 로고    scopus 로고
    • Tartrate-resistant acid phosphatase isoform 5b: A novel serum marker for monitoring bone disease in multiple myeloma
    • Terpos E, de la Fuente J, Syzdlo R, Hatjiharissi E, Viniou N, Meletis J, et al. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma. Int J Cancer 2003; 106: 455-457.
    • (2003) Int J Cancer , vol.106 , pp. 455-457
    • Terpos, E.1    de la Fuente, J.2    Syzdlo, R.3    Hatjiharissi, E.4    Viniou, N.5    Meletis, J.6
  • 16
    • 0043125544 scopus 로고    scopus 로고
    • Tartrate-resistant acid phosphatase 5b as a serum marker of bone metabolism in cancer patients
    • Mose S, Menzel C, Kurth AA, Obert K, Breidert I, Borowsky K, et al. Tartrate-resistant acid phosphatase 5b as a serum marker of bone metabolism in cancer patients. Anticancer Res 2003; 23: 2783-2788.
    • (2003) Anticancer Res , vol.23 , pp. 2783-2788
    • Mose, S.1    Menzel, C.2    Kurth, A.A.3    Obert, K.4    Breidert, I.5    Borowsky, K.6
  • 18
    • 34547636701 scopus 로고    scopus 로고
    • The semiquantitative bone scintigraphy index correlates with serum tartrate-resistant acid phosphatase activity in breast cancer patients with bone metastasis
    • Tsai SH, Chen CY, Ku CH, Janckila AJ, Yam LT, Yu JC, et al. The semiquantitative bone scintigraphy index correlates with serum tartrate-resistant acid phosphatase activity in breast cancer patients with bone metastasis. Mayo Clin Proc 2007; 82: 917-926.
    • (2007) Mayo Clin Proc , vol.82 , pp. 917-926
    • Tsai, S.H.1    Chen, C.Y.2    Ku, C.H.3    Janckila, A.J.4    Yam, L.T.5    Yu, J.C.6
  • 19
    • 37248999029 scopus 로고    scopus 로고
    • Treatment of early rheumatoid arthritis: A randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone
    • Durez P, Malghem J, Nzeusseu Toukap A, Depresseux G, Lauwerys BR, Westhorens R, et al. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone. Arthritis Rheum 2007; 56: 3919-3927.
    • (2007) Arthritis Rheum , vol.56 , pp. 3919-3927
    • Durez, P.1    Malghem, J.2    Nzeusseu, T.A.3    Depresseux, G.4    Lauwerys, B.R.5    Westhorens, R.6
  • 20
    • 42449098374 scopus 로고    scopus 로고
    • Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate
    • Kremer JM, Genant HK, Moreland LW, Russell AS, Emery P, Abud-Mendoza C, et al. Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate. Arthritis Rheum 2008; 58: 953-963.
    • (2008) Arthritis Rheum , vol.58 , pp. 953-963
    • Kremer, J.M.1    Genant, H.K.2    Moreland, L.W.3    Russell, A.S.4    Emery, P.5    Abud-Mendoza, C.6
  • 22
    • 24344433524 scopus 로고    scopus 로고
    • Osteoclast differentiation independent of the TRANCE-RANKTRAF6 axis
    • Kim N, Kadono Y, Takami M, Lee J, Lee SH, Okada F, et al. Osteoclast differentiation independent of the TRANCE-RANKTRAF6 axis. J Exp Med 2005; 202: 589-595.
    • (2005) J Exp Med , vol.202 , pp. 589-595
    • Kim, N.1    Kadono, Y.2    Takami, M.3    Lee, J.4    Lee, S.H.5    Okada, F.6
  • 23
    • 0035965998 scopus 로고    scopus 로고
    • Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of akt and erk
    • Lee SE, Chung WJ, Kwak HB, Chung CH, Kwack KB, Lee ZH, et al. Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of akt and erk. J Biol Chem 2001; 276: 49343-49349.
    • (2001) J Biol Chem , vol.276 , pp. 49343-49349
    • Lee, S.E.1    Chung, W.J.2    Kwak, H.B.3    Chung, C.H.4    Kwack, K.B.5    Lee, Z.H.6
  • 24
    • 10444273254 scopus 로고    scopus 로고
    • Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand
    • Lee CK, Lee EY, Chung SM, Mun SH, Yoo B, Moon HB. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand. Arthritis Rheum 2004; 50: 3831-3843.
    • (2004) Arthritis Rheum , vol.50 , pp. 3831-3843
    • Lee, C.K.1    Lee, E.Y.2    Chung, S.M.3    Mun, S.H.4    Yoo, B.5    Moon, H.B.6
  • 25
    • 34247592459 scopus 로고    scopus 로고
    • Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritis
    • Suematsu A, Tajiri Y, Nakashima T, Taka J, Ochi S, Oda H, et al. Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritis. Mod Rheumatol 2007; 17: 17-23.
    • (2007) Mod Rheumatol , vol.17 , pp. 17-23
    • Suematsu, A.1    Tajiri, Y.2    Nakashima, T.3    Taka, J.4    Ochi, S.5    Oda, H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.